N-4-(2-(BUTYL-METHYL-AMINO)-ETHYL)-N-2-(6-CHLORO-1H-BENZOIMIDAZOL-2-YL)-6-METHYL-PYRIMIDINE-2,4-DIAMINE
UNII D3W97L6U8L
Substance Identification & Data
This profile provides standardized clinical and technical data for N-4-(2-(butyl-methyl-amino)-ethyl)-n-2-(6-chloro-1h-benzoimidazol-2-yl)-6-methyl-pyrimidine-2,4-diamine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) D3W97L6U8L.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 42388-74-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C19H26ClN7 ZCZUTODAQODHEZ-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for N-4-(2-(butyl-methyl-amino)-ethyl)-n-2-(6-chloro-1h-benzoimidazol-2-yl)-6-methyl-pyrimidine-2,4-diamine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.